159 related articles for article (PubMed ID: 23001712)
1. Potential immunotargets for Alzheimer's disease treatment strategies.
Fernández PL; Britton GB; Rao KS
J Alzheimers Dis; 2013; 33(2):297-312. PubMed ID: 23001712
[TBL] [Abstract][Full Text] [Related]
2. Modeling Alzheimer's disease immune therapy mechanisms: interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide.
Lue LF; Walker DG
J Neurosci Res; 2002 Nov; 70(4):599-610. PubMed ID: 12404514
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy against APP beta-secretase cleavage site improves cognitive function and reduces neuroinflammation in Tg2576 mice without a significant effect on brain abeta levels.
Rakover I; Arbel M; Solomon B
Neurodegener Dis; 2007; 4(5):392-402. PubMed ID: 17536186
[TBL] [Abstract][Full Text] [Related]
4. Transgenic AD model mice, effects of potential anti-AD treatments on inflammation, and pathology.
van Groen T; Miettinen P; Kadish I
J Alzheimers Dis; 2011; 24(2):301-13. PubMed ID: 21239852
[TBL] [Abstract][Full Text] [Related]
5. In search of a treatment for Alzheimer's disease and potential immunonosuppresive therapeutic interventions.
Dhawan N; Puangco J; Jandial R
Neuro Endocrinol Lett; 2008 Aug; 29(4):410-20. PubMed ID: 18766151
[TBL] [Abstract][Full Text] [Related]
6. Involvement of inflammation in Alzheimer's disease pathogenesis and therapeutic potential of anti-inflammatory agents.
Shadfar S; Hwang CJ; Lim MS; Choi DY; Hong JT
Arch Pharm Res; 2015 Dec; 38(12):2106-19. PubMed ID: 26289122
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic redistribution of metal ions to treat Alzheimer's disease.
Crouch PJ; Barnham KJ
Acc Chem Res; 2012 Sep; 45(9):1604-11. PubMed ID: 22747493
[TBL] [Abstract][Full Text] [Related]
8. Potential therapeutic agents against Alzheimer's disease from natural sources.
Park SY
Arch Pharm Res; 2010 Oct; 33(10):1589-609. PubMed ID: 21052936
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for Alzheimer's disease.
Solomon B; Frenkel D
Neuropharmacology; 2010; 59(4-5):303-9. PubMed ID: 20388523
[TBL] [Abstract][Full Text] [Related]
10. Microglia as a potential bridge between the amyloid beta-peptide and tau.
Kitazawa M; Yamasaki TR; LaFerla FM
Ann N Y Acad Sci; 2004 Dec; 1035():85-103. PubMed ID: 15681802
[TBL] [Abstract][Full Text] [Related]
11. Novel approaches for immunotherapeutic intervention in Alzheimer's disease.
Vasilevko V; Cribbs DH
Neurochem Int; 2006 Jul; 49(2):113-26. PubMed ID: 16765487
[TBL] [Abstract][Full Text] [Related]
12. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Walker DG; Lue LF
J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and Alzheimer's disease.
Lee YJ; Han SB; Nam SY; Oh KW; Hong JT
Arch Pharm Res; 2010 Oct; 33(10):1539-56. PubMed ID: 21052932
[TBL] [Abstract][Full Text] [Related]
14. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?
Rogers J; Mastroeni D; Leonard B; Joyce J; Grover A
Int Rev Neurobiol; 2007; 82():235-46. PubMed ID: 17678964
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Alzheimer's disease.
Wang W; Fan L; Xu D; Wen Z; Yu R; Ma Q
Acta Biochim Biophys Sin (Shanghai); 2012 Oct; 44(10):807-14. PubMed ID: 22899646
[TBL] [Abstract][Full Text] [Related]
16. The role and therapeutic potential of monocytic cells in Alzheimer's disease.
Malm T; Koistinaho M; Muona A; Magga J; Koistinaho J
Glia; 2010 Jun; 58(8):889-900. PubMed ID: 20155817
[TBL] [Abstract][Full Text] [Related]
17. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
18. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down Syndrome.
Head E; Azizeh BY; Lott IT; Tenner AJ; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Apr; 8(2):252-65. PubMed ID: 11300721
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis and Alzheimer's disease.
Dal Bianco A; Bradl M; Frischer J; Kutzelnigg A; Jellinger K; Lassmann H
Ann Neurol; 2008 Feb; 63(2):174-83. PubMed ID: 17924575
[TBL] [Abstract][Full Text] [Related]
20. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
